Share
Eric Benjamin
Insulet Corporation, the global leader in tubeless insulin pump technology through its Omnipod® brand, has appointed Eric Benjamin as Chief Operating Officer.
In his expanded role, Benjamin will oversee Insulet’s end-to-end growth and innovation engine, setting strategy and guiding execution across new products, new markets, and commercial expansion. He will lead Strategy & Business Development, Research & Development, and the Office of the Chief Technology Officer, and a newly formed Growth organization, ensuring alignment to advance Insulet’s strategic priorities.
Since joining Insulet in 2015, Benjamin has played a pivotal role in shaping the company into an innovation-driven leader in diabetes care. He has been instrumental in launching Omnipod DASH® and Omnipod 5®, strengthening supply chain resilience, expanding into the type 2 diabetes market, and digitizing the customer experience to enhance engagement and satisfaction. Most recently, as Executive Vice President, Chief Product & Customer Experience Officer, he directed global product strategy, innovation roadmap, and commercial execution.
